Although we were not able to get access to TNBC patients that did not receive chemotherapy and therefore cannot definitively state that IRF9 predicts long-term chemotherapeutic outcome, our genetically altered mouse model does suggest that tumor inherent IFN status does predict improved outcomes in chemotherapy naïve and treated mice. Here, IFNA1 is linked to neoplasm.